OBE-2001

N/A

Report date: 2025/06/11 20:01:15

Base Information

Drug NameOBE-2001
Drug Alias Nameenteropeptidase inhibitors (ObeTherapy)OBE-1999OBE-2001OBE-2002OBE-2000
ClassificationBiologics > Protein drugs > Recombinant polypeptide
Mechanisms of ActionEnteropeptidase inhibitors
TargetsEnteropeptidase
Therapy Area/IndicationsObesityDiabetes Mellitus, Type 2
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryFrance
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesObeTherapy Biotechnology
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesObeTherapy Biotechnology
Active IndicationsN/A
Inactive IndicationsObesityDiabetes Mellitus, Type 2

Other Information

ATC CodeN/A
Related LinksN/A